Jafar M. B. Al-Shuhaib

Jafar M. B. Al-Shuhaib

Auto-generated profile, based on publicly available information

Jafar M. B. Al-Shuhaib

College of Medicine University of Warith Al‐Anbiyaa Karbala 56001 Iraq

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

4 November 2024 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
MAMohammed Baqur Al-Shuhaib
Mohammed Baqur Al-Shuhaib
JAJafar M. B. Al‐Shuhaib
Jafar M. B. Al‐Shuhaib

14 October 2023 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
MAMohammed Baqur Al-Shuhaib
Mohammed Baqur Al-Shuhaib
JAJafar M. B. Al-Shuhaib
Jafar M. B. Al-Shuhaib

22 January 2022 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
MAMohammed Baqur Al-Shuhaib
Mohammed Baqur Al-Shuhaib
HHHayder Hashim
Hayder Hashim
JAJafar M. B. Al-Shuhaib
Jafar M. B. Al-Shuhaib
DODaniel H. Obayes
Daniel H. Obayes
Main protease (Mpro) is a critical enzyme in the life cycle of severe acute respiratory syndrome Coronavirus −2 (SARS-CoV-2). Due to its essential role in the maturation of the polyproteins, the necessity to inhibit Mpro is one of the essential means to prevent the outbreak of COVID-19. In this context, this study was conducted on the natural compounds of medicinal plants that are commonly available in the Middle East to find out the most potent one to inhibit Mpro with the best bioavailability and druglikeness properties. A total of 3392 compounds of sixty-six medicinal plants were retrieved from PubChem database and docked against Mpro. Thirty compounds with the highest docking scores with Mpro were chosen for further virtual screening. Variable druglikeness and toxicity potentials of these compounds were evaluated using SwissADME and Protox servers respectively. Out of these virtually screened compounds, artecanin was predicted to exhibit the most favourable druglikeness potentials, accompanied by no predicted hepatoxicity, carcinogenicity, mutagenicity, and cytotoxicity. Molecular dynamics (MD) simulations showed that Mpro-artecanin complex exhibited comparable stability with that observed in the ligand-free Mpro. This study revealed for the first time that artecanin from Laurus nobilis provided a novel static and dynamic inhibition for Mpro with excellent safety, oral bioavailability, and pharmacokinetic profile. This study suggested the ability of artecanin to be used as a potential natural inhibitor that can be used to block or at least counteract the SARS-CoV-2 invasion. Communicated by Ramaswamy H. Sarma

3 August 2024 in Molecular Biotechnology
Verified
Journal Article
Closed access
PDF file
HHHayder Hashim
Hayder Hashim
JAJafar M. B. Al-Shuhaib
Jafar M. B. Al-Shuhaib
MMMudher K. Mohammed
Mudher K. Mohammed
MAMohammed Baqur Al-Shuhaib
Mohammed Baqur Al-Shuhaib

6 September 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
MAMohammed Baqur Al-Shuhaib
Mohammed Baqur Al-Shuhaib
SASarfaraz Alam
Sarfaraz Alam
SKSalman Ali Khan
Salman Ali Khan
HHHayder Hashim
Hayder Hashim
DODaniel H. Obayes
Daniel H. Obayes
JAJafar M. B. Al-Shuhaib
Jafar M. B. Al-Shuhaib
Resistin is a cysteine-rich secretory hormone that induces resistance to insulin, and its elevated expression is correlated with the onset of diabetes and several related metabolic disorders. Resistin performs its inhibitory role by connecting three identical subunits through Cys22-based disulfide linkages. The necessity to inhibit the formation of resistin trimer is one of the essential means to prevent the aggravation of diabetes mellitus type 2, obesity, and atherosclerosis. This study was conducted to screen the clinically approved drugs to find the most potent one to inhibit resistin with the best pharmacokinetics and drug-likeness properties. A total of 4654 clinically approved drugs were docked against the Cys22 residue of resistin. The top ten drugs with the highest high-precision (XP) docking scores were selected. Ioversol and masoprocol showed the highest XP docking and Molecular Mechanics-Generalized Born Surface Area (MMGBSA) scores, respectively, with double hydrogen bonding with the targeted Cys22. Molecular dynamics (MD) simulations showed that the masoprocol-resistin complex exhibited lower root mean square deviation (RMSD), radius of gyration, and root mean square fluctuation (RMSF) values than those observed in the ioversol-resistin complex. Both drugs induced drastic conformational changes in resistin monomer interactions. However, ioversol did not prove satisfying drug-likeness properties, while masoprocol showed the most favourable pharmacokinetic and drug-likeness properties. This study has demonstrated that masoprocol offers a novel inhibitory effect on resistin with the highest ligand affinity, making it a promising drug for combating insulin resistance.Communicated by Ramaswamy H. Sarma.